缩写名/全名 |
CANCER EPIDEM BIOMAR
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION |
||||||||||||||||||||
ISSN号 | 1055-9965 | ||||||||||||||||||||
研究方向 | 医学-公共卫生、环境卫生与职业卫生 | ||||||||||||||||||||
影响因子 | 2015:3.622, 2016:4.142, 2017:4.554, 2018:5.057, 2019:4.344, | ||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||
年文章数 | 245 | ||||||||||||||||||||
出版年份 | 1991 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 平均1.6月 |
||||||||||||||||||||
录用比例 | 约40% | ||||||||||||||||||||
投稿链接 | http://cebp.msubmit.net/cgi-bin/main.plex | ||||||||||||||||||||
投稿官网 | http://cebp.aacrjournals.org/ | ||||||||||||||||||||
h-index | 177 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1055-9965%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy. Author: Yuwen D1,2, Ma Y1, Wang D3, Gao J1, Li X1, Xue W1, Fan M1, Xu Q4, Shen Y4, Shu Y5. Journal: Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):163-173. doi: 10.1158/1055-9965.EPI-18-0569. Epub 2018 Sep 18. PubMed DOI |
2. | LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis. Author: Wang H#1, Song X#2, Huang Q#1, Xu T1, Yun D3, Wang Y3, Hu L3, Yan Y1, Chen H3, Lu D4, Chen J5. Journal: Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):760-769. doi: 10.1158/1055-9965.EPI-18-0638. Epub 2018 Oct 19. PubMed DOI |
3. | Host Characteristics and Risk of Incident Melanoma by Breslow Thickness. Author: Li WQ1,2,3, Cho E2,3,4, Wu S2,5, Li S6, Matthews NH2, Qureshi AA2,3,4. Journal: Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):217-224. doi: 10.1158/1055-9965.EPI-18-0607. Epub 2018 Oct 19. PubMed DOI |
4. | Circulating Plasma miRNAs as Potential Biomarkers of Non-Small Cell Lung Cancer Obtained by High-Throughput Real-Time PCR Profiling. Author: Niu Y#1, Su M#1,2, Wu Y1, Fu L3, Kang K4, Li Q1, Li L1, Hui G5, Li F6, Gou D7. Journal: Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):327-336. doi: 10.1158/1055-9965.EPI-18-0723. Epub 2018 Oct 30. PubMed DOI |
5. | Nicotine-N'-Oxidation by Flavin Monooxygenase Enzymes. Author: Perez-Paramo YX1, Chen G1, Ashmore JH1, Watson CJW1, Nasrin S1, Adams-Haduch J2, Wang R2, Gao YT3, Koh WP4,5, Yuan JM2,6, Lazarus P7. Journal: Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):311-320. doi: 10.1158/1055-9965.EPI-18-0669. Epub 2018 Oct 31. PubMed DOI |
6. | Vigorous Physical Activity Is Associated with Lower Risk of Metastatic-Lethal Progression in Prostate Cancer and Hypomethylation in the CRACR2A Gene. Author: Dai JY1,2, Wang B3, Wang X4, Cheng A2, Kolb S4, Stanford JL1,5, Wright JL4,6. Journal: Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):258-264. doi: 10.1158/1055-9965.EPI-18-0622. Epub 2018 Nov 21. PubMed DOI |
7. | A Population-Based Study on Liver Metastases in Women with Newly Diagnosed Breast Cancer. Author: Xie J1, Xu Z2. Journal: Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):283-292. doi: 10.1158/1055-9965.EPI-18-0591. Epub 2018 Nov 28. PubMed DOI |
8. | The Clinicopathologic and Prognostic Value of Hypoxia-Inducible Factor-2α in Cancer Patients: A Systematic Review and Meta-Analysis. Author: Luo D1, Liu H1, Lin D1, Lian K1, Ren H2. Journal: Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):857-866. doi: 10.1158/1055-9965.EPI-18-0881. Epub 2018 Dec 27. PubMed DOI |
9. | The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies. Author: Xu L#1, Zhang Y#2, Tang J1, Wang P1, Li L1, Yan X1, Zheng X1, Ren S1, Zhang M1, Xu M3. Journal: Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):867-881. doi: 10.1158/1055-9965.EPI-18-0570. Epub 2019 Jan 2. PubMed DOI |
10. | Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis. Author: Zhu Y#1, Wei Y#1,2,3, Zhang R#1,2,3, Dong X4, Shen S2, Zhao Y1,3, Bai J1, Albanes D5, Caporaso NE5, Landi MT5, Zhu B5, Chanock SJ5, Gu F6, Lam S7, Tsao MS8, Shepherd FA8, Tardon A9, Fernández-Somoano A9, Fernandez-Tardon G9, Chen C10, Barnett MJ10, Doherty J10, Bojesen SE11,12,13, Johansson M14, Brennan P14, McKay JD14, Carreras-Torres R14, Muley T15,16, Risch A16,17,18, Wichmann HE19, Bickeboeller H20, Rosenberger A20, Rennert G21, Saliba W21, Arnold SM22, Field JK23, Davies MPA23, Marcus MW23, Wu X24, Ye Y24, Le Marchand L25, Wilkens LR25, Melander O26, Manjer J26, Brunnström H27, Hung RJ28, Liu G28, Brhane Y28, Kachuri L28, Andrew AS29, Duell EJ30, Kiemeney LA31, van der Heijden EH31, Haugen A32, Zienolddiny S32, Skaug V32, Grankvist K33, Johansson M33, Woll PJ34, Cox A34, Taylor F34, Teare DM35, Lazarus P36, Schabath MB37, Aldrich MC38, Houlston RS39, McLaughlin J40, Stevens VL41, Shen H42, Hu Z42, Dai J42, Amos CI43, Han Y43, Zhu D43, Goodman GE44, Chen F45,3, Christiani DC45,2,3. Journal: Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):935-942. doi: 10.1158/1055-9965.EPI-18-0356. Epub 2019 Jan 30. PubMed DOI |
|
|